A new population-based study, published in CANCER, a journal of the American Cancer Society, has brought into sharp focus a…
Read More
Walk-In Lab Testing Expands Patient Access and Autonomy in West Virginia
The landscape of healthcare diagnostics is undergoing a profound transformation, with West Virginia emerging as a significant microcosm of a…
Read More
Sustaining Surveillance Amidst CDC Testing Pause: Clinical Laboratories Step Up to Safeguard Public Health
A temporary halt in infectious disease testing at the Centers for Disease Control and Prevention (CDC) has sent ripples through…
Read More
CMS Seeks Lab Input on Sweeping Anti-Fraud Rules Targeting Genetic Testing Overspending
With genetic test spending under the microscope, CMS is asking labs to help shape future anti-fraud rules—before formal proposals are…
Read More
WHO Introduces Faster, More Accessible TB Testing Strategies While CDC Maintains a Targeted, Risk-Based Approach in the United States
The global fight against tuberculosis (TB) has reached a pivotal juncture, with the World Health Organization (WHO) unveiling transformative new…
Read More
Keith J. Gray’s conviction underscores rising enforcement and audit risk as Medicare spending shifts toward high-cost genetic testing.
A federal jury in Dallas has delivered a resounding verdict, convicting Texas laboratory owner and former NFL player Keith J.…
Read More
Walk-in Lab Testing in West Virginia Accelerates Consumer-Driven Healthcare, Reshaping Diagnostic Access and Clinical Lab Models
The landscape of healthcare diagnostics is undergoing a profound transformation, with walk-in lab testing emerging as a pivotal force in…
Read More
WHO introduces faster, more accessible TB testing strategies while CDC maintains a targeted, risk-based approach in the United States.
The World Health Organization (WHO) has unveiled a set of groundbreaking new recommendations designed to revolutionize tuberculosis (TB) diagnostics, emphasizing…
Read More
University of Basel Researchers Replicate Human Bone Marrow in Landmark Study to Advance Blood Cancer Research and Reduce Animal Testing
In a significant breakthrough for regenerative medicine and oncology, researchers at the University of Basel and University Hospital Basel have…
Read More
Keith J. Gray’s conviction underscores rising enforcement and audit risk as Medicare spending shifts toward high-cost genetic testing.
A federal jury in Dallas has delivered a decisive verdict against Keith J. Gray, a 39-year-old Texas laboratory owner and…
Read MoreYOU MAY HAVE MISSED
